Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

King offers $1.4bn cash for fellow spec pharma Alpharma

Executive Summary

Hoping to create a synergistic combination of their specialty pharmaceutical businesses, King Pharmaceuticals has made an unsolicited offer of approximately $1.4bn cash to acquire public drug firm Alpharma. While King is being optimistic in stating the transaction could close by the end of 2008, Alpharma has already rejected the bid, saying it's not in the best interests of the shareholders and doesn't adequately value the company.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies